https://hormonejournal.com/news/stopping-glp-1-drugs-doubles-heart-attack-risk-canadian-patients-discontinuation Hormone Journal en 2026-11-12T00:00:00.000Z Stopping GLP-1 drugs doubles heart-attack risk: what Canadian patients need to know about discontinuation https://hormonejournal.com/news/fda-glp1-vision-loss-warning-canadian-patients-ozempic-wegovy Hormone Journal en 2026-11-11T00:00:00.000Z FDA GLP-1 vision-loss warning: what Canadian patients on weight-loss and diabetes drugs need to know